Search clinical trials for: AVN944

Total 3 results

Vertex Pharmaceuticals Incorporated
National Cancer Institute (NCI)

Withdrawn

A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors

Refractory Solid Tumors

United States
Vertex Pharmaceuticals Incorporated

Terminated

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

Pancreatic Cancer

United States
Institute for Neurodegenerative Disorders

Terminated

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects (AV94)

Alzheimer Disease

United States

3

Subscribe